199 related articles for article (PubMed ID: 28984277)
1. A multicentre audit of HDR/PDR brachytherapy absolute dosimetry in association with the INTERLACE trial (NCT015662405).
Díez P; Aird EGA; Sander T; Gouldstone CA; Sharpe PHG; Lee CD; Lowe G; Thomas RAS; Simnor T; Bownes P; Bidmead M; Gandon L; Eaton D; Palmer AL
Phys Med Biol; 2017 Nov; 62(23):8832-8849. PubMed ID: 28984277
[TBL] [Abstract][Full Text] [Related]
2. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
[TBL] [Abstract][Full Text] [Related]
3. End-to-end dosimetric audit: A novel procedure developed for Irish HDR brachytherapy centres.
Bassi S; Berrigan L; Zuchora A; Fahy L; Moore M
Phys Med; 2020 Dec; 80():221-229. PubMed ID: 33190078
[TBL] [Abstract][Full Text] [Related]
4. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
[TBL] [Abstract][Full Text] [Related]
5. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
[TBL] [Abstract][Full Text] [Related]
6. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
7. Suitability of microDiamond detectors for the determination of absorbed dose to water around high-dose-rate
Kaveckyte V; Malusek A; Benmakhlouf H; Alm Carlsson G; Carlsson Tedgren Å
Med Phys; 2018 Jan; 45(1):429-437. PubMed ID: 29171060
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a lithium formate EPR dosimetry system for dose measurements around 192Ir brachytherapy sources.
Antonovic L; Gustafsson H; Carlsson GA; Carlsson Tedgren A
Med Phys; 2009 Jun; 36(6):2236-47. PubMed ID: 19610313
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of water-mimicking solid phantom materials for use in HDR and LDR brachytherapy dosimetry.
Schoenfeld AA; Thieben M; Harder D; Poppe B; Chofor N
Phys Med Biol; 2017 Nov; 62(24):N561-N572. PubMed ID: 29072195
[TBL] [Abstract][Full Text] [Related]
10. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
11. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
12. Measurement of absorbed dose-to-water for an HDR (192)Ir source with ionization chambers in a sandwich setup.
Araki F; Kouno T; Ohno T; Kakei K; Yoshiyama F; Kawamura S
Med Phys; 2013 Sep; 40(9):092101. PubMed ID: 24007170
[TBL] [Abstract][Full Text] [Related]
13. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
[TBL] [Abstract][Full Text] [Related]
14. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
Awunor O; Berger D; Kirisits C
Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
[TBL] [Abstract][Full Text] [Related]
15. Positional and angular tracking of HDR
Aldelaijan S; Devic S; Bekerat H; Papaconstadopoulos P; Schneider J; Seuntjens J; Cormack RA; Buzurovic IM
Med Phys; 2020 Dec; 47(12):6122-6139. PubMed ID: 33064876
[TBL] [Abstract][Full Text] [Related]
16. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
Austerlitz C; Campos CA
Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
[TBL] [Abstract][Full Text] [Related]
17. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry.
Casey KE; Alvarez P; Kry SF; Howell RM; Lawyer A; Followill D
Med Phys; 2013 Nov; 40(11):112102. PubMed ID: 24320455
[TBL] [Abstract][Full Text] [Related]
18. 3D source tracking and error detection in HDR using two independent scintillator dosimetry systems.
Linares Rosales HM; Johansen JG; Kertzscher G; Tanderup K; Beaulieu L; Beddar S
Med Phys; 2021 May; 48(5):2095-2107. PubMed ID: 33222208
[TBL] [Abstract][Full Text] [Related]
19. Source position verification and dosimetry in HDR brachytherapy using an EPID.
Smith RL; Taylor ML; McDermott LN; Haworth A; Millar JL; Franich RD
Med Phys; 2013 Nov; 40(11):111706. PubMed ID: 24320414
[TBL] [Abstract][Full Text] [Related]
20. On the experimental validation of model-based dose calculation algorithms for
Pappas EP; Zoros E; Moutsatsos A; Peppa V; Zourari K; Karaiskos P; Papagiannis P
Phys Med Biol; 2017 May; 62(10):4160-4182. PubMed ID: 28353447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
